Dissecting signaling regulators driving AXL-mediated bypass resistance and associated phenotypes by phosphosite perturbations.
Marc CreixellScott D TaylorJacqueline GerritsenSong Yi BaeMingxuan JiangTeresa AugustinMichelle LouiCarmen BoixoPau CreixellForest M WhiteAaron S MeyerPublished in: bioRxiv : the preprint server for biology (2023)
A systems biology approach elucidates the signaling pathways driving AXL-mediated erlotinib resistance in lung cancer.